Login
$RPID
$0.73 -$0.01 (1.35%) After hours

$RPID 8-K SEC Filings

Filed On Filing
16 Nov 2026 8-K: Entry into a Material Definitive Agreement; Other Events
16 Nov 2026 8-K: Results of Operations and Financial Condition

Lexington, MA, November 16, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient ...

07 Aug 2026 8-K: Results of Operations and Financial Condition

Lexington, MA, August 7, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient man...

28 May 2026 8-K: Submission of Matters to a Vote of Security Holders

The Company held its annual meeting of stockholders on May 21, 2026 (the “Annual Meeting”), at which a quorum was present. There were two items of business acted upon by the stockholders. There were 41,267,511 shares of the Company’s Cla...

19 May 2026 8-K: Entry into a Material Definitive Agreement

1. Introductory. Rapid Micro Biosystems, Inc., a Delaware corporation (the “Company”), proposes to sell, pursuant to the terms of this Underwriting Agreement (this “Agreement”), to the several underwriters named in Schedule A hereto (the...

13 May 2026 8-K: Results of Operations and Financial Condition

Lexington, MA, May 13, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manuf...

27 Mar 2026 8-K: Departure/Election of Directors or Officers; Compensation

This letter agreement follows our conversations regarding your employment with Rapid Micro Biosystems, Inc. (the “Company”). Reference is made your Employment Agreement, dated as of July 8, 2021, between you and the Company (the “Employm...

12 Mar 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

Lexington, Mass., March 12, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient ...

13 Jan 2026 8-K: Results of Operations and Financial Condition

LEXINGTON, Mass., January 13, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficien...

07 Nov 2025 8-K: Results of Operations and Financial Condition

Rapid Micro Biosystems Reports Third Quarter 2025 Financial Results; Announces Record Multi-System Customer Order and Raises Full-Year Revenue and System Placement Guidance

12 Aug 2025 8-K: Entry into a Material Definitive Agreement; Results of Operations and Financial Condition +3 more

Lexington, MA, August 12, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient ma...

17 Jun 2025 8-K: Other Events

I am writing on a personal note to let you know that I was recently diagnosed with a treatable form of Lymphoma. The good news is that I have an excellent care team and my doctors have given me a very good prognosis.

23 May 2025 8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

09 May 2025 8-K: Results of Operations and Financial Condition

Lexington, MA, May 9, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufa...

04 Mar 2025 8-K: Regulation FD Disclosure

Rapid Micro Biosystems TD Cowen 45th Annual Health Care Conference Robert Spignesi, President & CEO March 4, 2025 R A P I D M I C R O B I O S Y S T E M S N A S D A Q : R P I D © 2025, Rapid Micro Biosystems, Inc. | RAPID MICRO BIOSYSTEMS...

28 Feb 2025 8-K: Results of Operations and Financial Condition

Lexington, Mass., February 28, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficie...

27 Feb 2025 8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure

Rapid Micro Biosystems Announces Global Distribution and Collaboration Agreement with the Life Science business of Merck KGaA, Darmstadt, Germany

16 Jan 2025 8-K: Regulation FD Disclosure

Rapid Micro Biosystems 43rd Annual J.P. Morgan Healthcare Conference Rob Spignesi, President & CEO January 16, 2025 R A P I D M I C R O B I O S Y S T E M S N A S D A Q : R P I D © 2025, Rapid Micro Biosystems, Inc. | RAPID MICRO BIOSYSTE...

14 Jan 2025 8-K: Results of Operations and Financial Condition

LEXINGTON, Mass., January 14, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficien...

12 Nov 2024 8-K: Other Events

As previously reported, on February 2, 2024, Rapid Micro Biosystems, Inc. (the “Company”) received a notification letter from the Nasdaq Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC notifying the Company that...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support